z-logo
Premium
[ 32 P]2‐iodo‐ N 6 ‐methyl‐( N )‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate ([ 32 P]MRS2500), a novel radioligand for quantification of native P2Y 1 receptors
Author(s) -
Houston Dayle,
Ohno Michihiro,
Nicholas Robert A,
Jacobson Kenneth A,
Harden T Kendall
Publication year - 2006
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0706453
Subject(s) - radioligand , receptor , binding site , sf9 , radioligand assay , p2y receptor , ligand binding assay , biochemistry , stereochemistry , biology , chemistry , agonist , recombinant dna , spodoptera , gene
Analysis of the P2Y family of nucleotide‐activated G‐protein‐coupled receptors has been compromised by the lack of selective high‐affinity, high‐specific‐radioactivity radioligands. We have pursued quantification of the P2Y 1 receptor through the development of a series of selective P2Y 1 receptor antagonists. Recently, we synthesized 2‐iodo‐ N 6 ‐methyl‐( N )‐methanocarba‐2′‐deoxyadenosine 3′,5′‐bisphosphate (MRS2500), a selective, competitive antagonist that exhibits a K i of 0.8 n M in competition‐binding assays with [ 3 H]MRS2279. A 3′‐monophosphate precursor molecule, MRS2608, was radiolabeled at the 5′ position with 32 P using polynucleotide kinase and [ γ 32 P]ATP to yield [ 32 P]MRS2500. [ 32 P]MRS2500 bound selectively to Sf9 insect cell membranes expressing the human P2Y 1 receptor (Sf9‐P2Y 1 ), but did not detectably bind membranes expressing other P2Y receptors. P2Y 1 receptor binding to [ 32 P]MRS2500 was saturable with a K D of 1.2 n M . Agonists and antagonists of the P2Y 1 receptor inhibited [ 32 P]MRS2500 binding in Sf9‐P2Y 1 membranes with values in agreement with those observed in functional assays of the P2Y 1 receptor. A high‐affinity binding site for [ 32 P]MRS2500 ( K D =0.33 n M ) was identified in rat brain, which exhibited the pharmacological selectivity of the P2Y 1 receptor. Distribution of this binding site varied among rat tissues, with the highest amount of binding appearing in lung, liver, and brain. Among brain regions, distribution of the [ 32 P]MRS2500 binding site varied by six‐fold, with the highest and lowest amounts of sites detected in cerebellum and cortex, respectively. Taken together, these data illustrate the synthesis and characterization of a novel P2Y 1 receptor radioligand and its utility for examining P2Y 1 receptor expression in native mammalian tissues.British Journal of Pharmacology (2006) 147 , 459–467. doi: 10.1038/sj.bjp.0706453

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom